1. Describe present limitations to drug development in neuro-oncology (and secondarily in neurology)
  2. Describe experimental approaches to enhance our understanding of drug CNS penetration (directly and indirectly)
  3. Provide a specific example of how pharmacodynamic imaging could advance patient care in neuro-oncology. 
Session date: 
03/13/2026 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. David Kamson